Logo

Pfizer to Use GenoLogics Informatics Worldwide

Nov 10, 2008
NEW YORK (GenomeWeb news) – GenoLogics said today that Pfizer will license its lab and data management software under a three-year, global agreement.
 
Victoria, British Columbia-based GenoLogics said Pfizer will use its software suite to “capture, contextualize and integrate science data in multiple locations worldwide.”
 
The GenoLogics integrated software products are used for “managing biorepositories and clinical annotations to lab and data management systems for genomics, proteomics and other sciences,” the company said.
 
Pfizer’s Head of BBC Informatics, Giles Day, said that the GenoLogics software “can be customized at the lab level, including instrument integrations and data imports, while allowing us to analyze data across sciences and labs.”
 
Financial terms of the agreement were not released.

Filed under

Informatics
Breaking News
The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.